Patexia Research

Case number 2:21-cv-20099

Lawsuits

CELGENE CORPORATION v. ALEMBIC PHARMACEUTICALS LIMITED > Summary

Court Case Number 2:21-cv-20099

Filing Date Nov 18, 2021

Termination Date Jul 5, 2022

Court New Jersey District Court

Status Judgment - Judgment on Consent

JudgesSusan D. Wigenton, Leda D. Wettre

Plaintiff

Defendant

Alembic Pharmaceuticals Ltd.

Plaintiff Attorneys

13

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Brian Forsatz
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: Nicholas Anthony Locastro
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Celgene
Attorney Name: Matthew J. Hertko
Jones Day

Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Gabriel P. Brier
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan

Defendant Attorneys

9

Alembic Pharmaceuticals Ltd.
Attorney Name: Eric I. Abraham
Hill Wallack LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: Joseph T. Jaros
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Adrianne C. Rose
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Thomas H. Ehrich
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Matthew V. Anderson
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: Lauren M. Lesko
Rakoczy Molino Mazzochi Siwik

Alembic Pharmaceuticals Ltd.
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik

Counter Defendant

3

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Counter Claimant

3

Alembic Pharmaceuticals, Inc.
Attorney Name: Eric I. Abraham
Hill Wallack LLP

alembic global holding sa
Attorney Name: Eric I. Abraham
Hill Wallack LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: Eric I. Abraham
Hill Wallack LLP

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
09101621	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation	Aug 11, 2015
09101622	Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone	Aug 11, 2015
08648095	Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor	Feb 11, 2014
08530498	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione	Sep 10, 2013
07968569	Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione	Jun 28, 2011
07855217	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 21, 2010
07465800	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 16, 2008